Effectiveness of tocilizumab in non-intubated cases with COVID-19: a systematic review and meta-analysis

PURPOSE: Tocilizumab, a monoclonal IL-6 receptor blocker, is an effective agent for severe-to-critical cases of COVID-19; however, its target patients for the optimum use need to be detailed. We performed a systematic review and meta-analysis to define its effect among severely ill but non-intubated...

Descripción completa

Detalles Bibliográficos
Autores principales: Keske, Şiran, Akyol, Merve, Tanrıöver, Cem, Özlüşen, Batu, Akcan, Rüştü Emre, Güler, Ulaş, Sait, Bilgin, Kaçmaz, Bahar, Gönen, Mehmet, Ergönül, Önder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170028/
https://www.ncbi.nlm.nih.gov/pubmed/37162716
http://dx.doi.org/10.1007/s15010-023-02047-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170028/
https://www.ncbi.nlm.nih.gov/pubmed/37162716
http://dx.doi.org/10.1007/s15010-023-02047-2

Ejemplares similares